Therefore, the study aimed at evaluating whether EAT volume or thickness, as an imaging biomarker, can predict poor prognosis in patients with different types of HF and to provide comprehensive data on the heterogeneity of EAT measurement protocols and metrics originating from different studies. The gene discussed is MCL1; the disease is hydrops fetalis.